BILLERICA, Mass. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020 . Second Quarter 2020 Summary Total revenue of $19.5 million , a decrease of 1% year-over-year on a reported and constant currency basis.

BILLERICA, Mass. , July 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place between August 11 and 13, 2020 .

Earnings Call to be Hosted on August 5, 2020 BILLERICA, Mass. , July 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to

iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conformis BILLERICA, Mass. , June 22, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation

Conformis and Zimmer Biomet settled disputes related to Patient-Specific Instrument Patents for Use with Off-the-Shelf Knee, Hip, and Shoulder Implants BILLERICA, Mass. , May 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license

Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family Foundation for his scientific computer-and-image-based workflow to optimize knee implant design BILLERICA, Mass. , May 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc.

BILLERICA, Mass. , May 11, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient's unique

BILLERICA, Mass. , May 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, May 11, 2020 , at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2020 .  The webcast will be

Government Relief, Anticipated Relaxing of Restrictions on Elective Surgeries Leads to Return to Work BILLERICA, Mass. , April 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that, due in large part to a loan made available to the Company under the Paycheck Protection

BILLERICA, Mass. , April 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (NASDAQ:EWBC) under the Paycheck Protection Program (“PPP”) offered by the U.S.

BILLERICA, Mass. , April 09, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS) today announced that, due to the public health impact of the novel coronavirus outbreak and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being

Withdraws Previous 2020 Growth Outlook Implementing furlough of approximately 1/3 of its direct workforce and substantially all of its temporary workforce Furloughed employees will be immediately eligible for unemployment benefits and will maintain their existing healthcare coverage through

BILLERICA, Mass. , March 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today financial results for the fourth quarter and year ended December 31, 2019 . Q4 Summary Total revenue of $19.9 million , down 10% year-over-year on a reported basis and 9% on a constant currency

BILLERICA, Mass. , Feb. 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped,

BILLERICA, Mass. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, March 2, 2020 , at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31 , 2019. 

Rating Highlights Positive Five-Year Survivorship Following Total Knee Arthroplasty BILLERICA, Mass. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and

Also Announces Gary Maingot as SVP, Operations; New Executive Leadership Team Members Contribute Deep Functional Expertise and Technical Knowledge; Inducement Grants Reported BILLERICA, Mass. , Feb. 05, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses

Conformis’ Patient-Specific Knee Implant Technology Is Complemented by New 3D-designed Hip System Launched in November 2019 BILLERICA, Mass. , Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology

BILLERICA, Mass. and SAN FRANCISCO , Jan. 14, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique